Viewing Study NCT04395456


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2025-12-25 @ 9:11 PM
Study NCT ID: NCT04395456
Status: UNKNOWN
Last Update Posted: 2021-02-21
First Post: 2020-05-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)
Sponsor: Amyndas Pharmaceuticals S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module